Arcutis Biotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Arcutis Biotherapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $-0.33 | $-0.42 | 21.4 % |
Jun 2024 | 2024-08-14 | $-0.42 | $-0.57 | 26.3 % |
Mar 2024 | 2024-05-14 | $-0.32 | $-0.73 | 56.2 % |
Dec 2023 | 2024-02-27 | $-0.72 | $-0.77 | 6.49 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $44.76M | $37.62M | 19.0 % |
Jun 2024 | 2024-08-14 | $30.86M | $27.12M | 13.8 % |
Mar 2024 | 2024-05-14 | $49.57M | $14.68M | 237.7 % |
Dec 2023 | 2024-02-27 | $13.53M | $11.34M | 19.3 % |
Arcutis Biotherapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3.
Arcutis Biotherapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3 and the Actual EPS was $-0.33, which beat the estimate of $-0.42.
Arcutis Biotherapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.